Impact of Practice Facilitation in Primary Care on Chronic Disease Care Processes and Outcomes: a Systematic Review

The objective is to evaluate the impact of practice facilitation on chronic disease outcomes in the primary care setting.MethodsThis systematic review examined North American studies from PubMed, EMBASE, and Web of Science (database inception to August 2017). Investigators independently extracted and assessed the quality of the data on chronic disease process and clinical outcome measures. Studies implemented practice facilitation and reported quantifiable care processes and patient outcomes for chronic disease. Each study and their evidence were assessed for risk of bias and quality according to the Cochrane Collaboration and the Grade Collaboration tool.ResultsThis systematic review included 25 studies: 12 randomized control trials and 13 prospective cohort studies. Across all studies, practices and their clinicians were aware of the implementation of practice facilitation. Improvements were observed in most studies for chronic diseases including asthma, cancer (breast, cervical, and colorectal), cardiovascular disease (cerebrovascular disease, coronary artery disease, dyslipidemia, hypertension, myocardial infarction, and peripheral vascular disease), and type 2 diabetes. Mixed results were observed for chronic kidney disease and chronic illness care.DiscussionOverall, the results suggest that practice facilitation may improve chronic disease care measures. Across all studies, practices were aware of practice facilitation. These findings lend support for the potential expa...
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research

Related Links:

ConclusionLower levels of antioxidant enzymes and non-enzymatic small molecules and higher levels of oxidative stress and inflammatory clinical parameters such as NO, MDA, TNF-α and MMP-9 may be involved in the pathogenesis of systemic chemotherapy related ocular complications such as cataract, glaucoma, blepharitis, retinitis pigmentosa, macular degeneration, pterygium and retinal degeneration etc.
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
Publication date: Available online 12 August 2018Source: Saudi Journal of Biological SciencesAuthor(s): Arjunan Venkatachalapathi, Krishnaswamy Thenmozhi, Krishnamoorthy Karthika, Mohammad Ajmal Ali, Subramaniyam Paulsamy, Fahad AlHemaid, Mohamed Soliman ElshikhAbstractSolena amplexicaulis (Lam.) Gandhi (Family Cucurbitaceae) is one of the important plant species used by the Irula tribes of Walayar valley of southern Western Ghats, India for the management of diabetes. To confirm the antidiabetic property of S. amplexicaulis, the present study was addressed using crude methanolic leaf extract of S. amplexicaulis (MeOHSa) a...
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
Publication date: Available online 12 August 2018Source: Urology Case ReportsAuthor(s): Félix Couture, Joshua Chin, Jaron Chong, Simon Tanguay
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
Conclusions: Here, we showed that functional cooperative miRNAs effectively suppressed erbB3 expression. This novel approach targeting of HER3 was able to enhance the therapeutic efficacy of trastuzumab and paclitaxel against HER2-overexpressing breast cancer. PMID: 30093840 [PubMed]
Source: Biological Procedures Online - Category: Molecular Biology Authors: Tags: Biol Proced Online Source Type: research
Discussion: Metacarpophalangeal hyperextension appears to be a factor of poor prognosis for surgical treatment of trapeziometacarpal osteoarthritis when it is not managed. TMP provides better metacarpophalangeal stabilization by restoring thumb length and would avoid surgery on the metacarpophalangeal joint. TMP may be recommended in patients having symptomatic trapezio-metacarpal joint osteoarthritis and MCP joint hyperextension.Level of evidence: III, retrospective observational case control study.
Source: Orthopaedics and Traumatology: Surgery and Research - Category: Orthopaedics Source Type: research
Researchers say patients are scared into invasive treatments for conditions unlikely to do harmThe word “cancer” should be dropped from some medical diagnoses because the term can scare people into invasive treatments they do not need, Australian and US researchers say.An analysis published by the British Medical Journal on Monday described “cancer” as particularly problematic when used to describe some thyroid cancers less than 1cm in size, some low and intermediate grade breast cancers, andlocalised prostate cancer.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Cancer Cancer research Health Australia news Science Medical research Society World news Source Type: news
By MATTHEW HOLT Happy 15th birthday THCB! Yes, 15 years ago today this little blog opened for business and changed my life (and at least impacted a few others). Later this week we are going to celebrate and tell you a bit more about what the next 15 years (really?) of THCB might look like. But for now, I’m rerunning a few of my favorite pieces from the mid-2000s, the golden age of blogging. Today I present “Health Care = Communism + Frappuccinos”, one of my favorites about the relationship between government and private sector originally published here on Jan7, 2005. And like the Medicare one from last we...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Matthew Holt OP-ED 15th Birthday Celebration Commumism Frappuchinos Source Type: blogs
Diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD) both increase the risk for a major adverse cardiac event, and are therefore considered priority conditions clinically. Although guidelines encourage clinicians to treat them similarly, many researchers do not consider DM an ASCVD risk-equivalent. However, from a healthcare system standpoint it is more important to determine whether DM is an economic burden equivalent to ASCVD. Using data from the Household Component of the 2010–2013 Medical Expenditure Panel Survey, we determined that the diagnosis of DM yields significantly lower healthcare ex...
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Short Report Source Type: research
No abstract available
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Correspondence Source Type: research
In conclusion, cyclophosphamide is a cheap drug that may be useful in a number of glomerular diseases but it may lead to severe side effects. A close monitoring of blood count and clinical conditions, as well as low cumulative doses of cyclophosphamide are strongly recommended when using the drug in patients with renal diseases.
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research
More News: Asthma | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cervical Cancer | Chronic Kidney Disease | Colorectal Cancer | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Health Management | Heart | Heart Attack | Hypertension | Internal Medicine | Peripheral Vascular Disease (PVD) | Primary Care | Science | Study | Urology & Nephrology | USA Health